• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用患者特异性诱导多能干细胞构建婴儿型庞贝病的骨骼肌模型。

A Skeletal Muscle Model of Infantile-onset Pompe Disease with Patient-specific iPS Cells.

机构信息

Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, 606-8507, Japan.

Department of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, 606-8507, Japan.

出版信息

Sci Rep. 2017 Oct 18;7(1):13473. doi: 10.1038/s41598-017-14063-y.

DOI:10.1038/s41598-017-14063-y
PMID:29044175
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5647434/
Abstract

Pompe disease is caused by an inborn defect of lysosomal acid α-glucosidase (GAA) and is characterized by lysosomal glycogen accumulation primarily in the skeletal muscle and heart. Patients with the severe type of the disease, infantile-onset Pompe disease (IOPD), show generalized muscle weakness and heart failure in early infancy. They cannot survive over two years. Enzyme replacement therapy with recombinant human GAA (rhGAA) improves the survival rate, but its effect on skeletal muscle is insufficient compared to other organs. Moreover, the patho-mechanism of skeletal muscle damage in IOPD is still unclear. Here we generated induced pluripotent stem cells (iPSCs) from patients with IOPD and differentiated them into myocytes. Differentiated myocytes showed lysosomal glycogen accumulation, which was dose-dependently rescued by rhGAA. We further demonstrated that mammalian/mechanistic target of rapamycin complex 1 (mTORC1) activity was impaired in IOPD iPSC-derived myocytes. Comprehensive metabolomic and transcriptomic analyses suggested the disturbance of mTORC1-related signaling, including deteriorated energy status and suppressed mitochondrial oxidative function. In summary, we successfully established an in vitro skeletal muscle model of IOPD using patient-specific iPSCs. Disturbed mTORC1 signaling may contribute to the pathogenesis of skeletal muscle damage in IOPD, and may be a potential therapeutic target for Pompe disease.

摘要

庞贝病是由溶酶体酸性α-葡萄糖苷酶(GAA)的先天缺陷引起的,其特征是溶酶体糖原主要在骨骼肌和心脏中积累。严重型患者,婴儿起病型庞贝病(IOPD),在婴儿早期表现为全身肌肉无力和心力衰竭。他们无法存活超过两年。重组人 GAA(rhGAA)的酶替代疗法提高了生存率,但与其他器官相比,其对骨骼肌的作用仍不充分。此外,IOPD 中骨骼肌损伤的病理机制仍不清楚。在这里,我们从 IOPD 患者中生成诱导多能干细胞(iPSC)并将其分化为肌细胞。分化的肌细胞表现出溶酶体糖原积累,rhGAA 可呈剂量依赖性地挽救。我们进一步证明,IOPD iPSC 衍生的肌细胞中哺乳动物/雷帕霉素靶蛋白复合物 1(mTORC1)活性受损。综合代谢组学和转录组学分析表明,mTORC1 相关信号通路受到干扰,包括能量状态恶化和线粒体氧化功能受抑制。总之,我们使用患者特异性 iPSC 成功建立了 IOPD 的体外骨骼肌模型。受损的 mTORC1 信号可能有助于 IOPD 中骨骼肌损伤的发病机制,并且可能是庞贝病的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/5647434/3ebc889acc1c/41598_2017_14063_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/5647434/a11c247c3fa2/41598_2017_14063_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/5647434/dca55372d42e/41598_2017_14063_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/5647434/cc2484900642/41598_2017_14063_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/5647434/bf0d83203e0e/41598_2017_14063_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/5647434/a48903d6f8fe/41598_2017_14063_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/5647434/e4331bd9e0c7/41598_2017_14063_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/5647434/3ebc889acc1c/41598_2017_14063_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/5647434/a11c247c3fa2/41598_2017_14063_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/5647434/dca55372d42e/41598_2017_14063_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/5647434/cc2484900642/41598_2017_14063_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/5647434/bf0d83203e0e/41598_2017_14063_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/5647434/a48903d6f8fe/41598_2017_14063_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/5647434/e4331bd9e0c7/41598_2017_14063_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3208/5647434/3ebc889acc1c/41598_2017_14063_Fig7_HTML.jpg

相似文献

1
A Skeletal Muscle Model of Infantile-onset Pompe Disease with Patient-specific iPS Cells.利用患者特异性诱导多能干细胞构建婴儿型庞贝病的骨骼肌模型。
Sci Rep. 2017 Oct 18;7(1):13473. doi: 10.1038/s41598-017-14063-y.
2
A Liver Model of Infantile-Onset Pompe Disease Using Patient-Specific Induced Pluripotent Stem Cells.使用患者特异性诱导多能干细胞构建的婴儿型庞贝病肝脏模型
Front Cell Dev Biol. 2019 Nov 29;7:316. doi: 10.3389/fcell.2019.00316. eCollection 2019.
3
Three-dimensional tissue-engineered human skeletal muscle model of Pompe disease.庞贝氏病的三维组织工程化人骨骼肌模型。
Commun Biol. 2021 May 5;4(1):524. doi: 10.1038/s42003-021-02059-4.
4
Gene Therapy for Pompe Disease: The Time is now.庞贝病的基因治疗:现在是时候了。
Hum Gene Ther. 2019 Oct;30(10):1245-1262. doi: 10.1089/hum.2019.109. Epub 2019 Sep 9.
5
CRISPR-mediated generation and characterization of a Gaa homozygous c.1935C>A (p.D645E) Pompe disease knock-in mouse model recapitulating human infantile onset-Pompe disease.CRISPR 介导的 Gaa 纯合 c.1935C>A(p.D645E)庞贝病敲入小鼠模型的建立与特征分析,该模型模拟了人类婴儿期发病-庞贝病。
Sci Rep. 2022 Dec 14;12(1):21576. doi: 10.1038/s41598-022-25914-8.
6
Suppression of mTORC1 activation in acid-α-glucosidase-deficient cells and mice is ameliorated by leucine supplementation.缺乏酸性α-葡萄糖苷酶的细胞和小鼠中 mTORC1 激活的抑制作用可通过补充亮氨酸得到改善。
Am J Physiol Regul Integr Comp Physiol. 2014 Nov 15;307(10):R1251-9. doi: 10.1152/ajpregu.00212.2014. Epub 2014 Sep 17.
7
CRISPR-Cas9 generated Pompe knock-in murine model exhibits early-onset hypertrophic cardiomyopathy and skeletal muscle weakness.CRISPR-Cas9 基因编辑生成的庞贝氏症敲入鼠模型表现出早发性肥厚型心肌病和骨骼肌无力。
Sci Rep. 2020 Jun 25;10(1):10321. doi: 10.1038/s41598-020-65259-8.
8
Antibody-mediated enzyme replacement therapy targeting both lysosomal and cytoplasmic glycogen in Pompe disease.针对庞贝病中溶酶体和细胞质糖原的抗体介导酶替代疗法。
J Mol Med (Berl). 2017 May;95(5):513-521. doi: 10.1007/s00109-017-1505-9. Epub 2017 Feb 2.
9
Treatment of infantile-onset Pompe disease in a rat model with muscle-directed AAV gene therapy.肌肉靶向 AAV 基因治疗治疗婴儿期发病庞贝病的大鼠模型。
Mol Metab. 2024 Mar;81:101899. doi: 10.1016/j.molmet.2024.101899. Epub 2024 Feb 10.
10
The generation of induced pluripotent stem cells (iPSCs) from patients with infantile and late-onset types of Pompe disease and the effects of treatment with acid-α-glucosidase in Pompe's iPSCs.来自婴儿型和晚发型庞贝病患者的诱导多能干细胞(iPSC)的生成以及酸性α-葡萄糖苷酶对庞贝病iPSC的治疗效果。
Mol Genet Metab. 2014 May;112(1):44-8. doi: 10.1016/j.ymgme.2014.02.012. Epub 2014 Mar 4.

引用本文的文献

1
MicroRNA-33 inhibition ameliorates muscular dystrophy by enhancing skeletal muscle regeneration.微小RNA-33抑制通过增强骨骼肌再生改善肌肉萎缩症。
EMBO Mol Med. 2025 Jul 23. doi: 10.1038/s44321-025-00273-9.
2
Aligning with the 3Rs: alternative models for research into muscle development and inherited myopathies.与 3Rs 保持一致:肌肉发育和遗传性肌肉疾病研究的替代模型。
BMC Vet Res. 2024 Oct 18;20(1):477. doi: 10.1186/s12917-024-04309-z.
3
Possible involvement of zinc transporter ZIP13 in myogenic differentiation.锌转运蛋白 ZIP13 可能参与肌生成分化。

本文引用的文献

1
Metabolomic Profiling of Pompe Disease-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveals That Oxidative Stress Is Associated with Cardiac and Skeletal Muscle Pathology.庞贝病诱导多能干细胞衍生心肌细胞的代谢组学分析揭示氧化应激与心脏和骨骼肌病变有关。
Stem Cells Transl Med. 2017 Jan;6(1):31-39. doi: 10.5966/sctm.2015-0409. Epub 2016 Aug 18.
2
Modulation of mTOR signaling as a strategy for the treatment of Pompe disease.调节mTOR信号通路作为治疗庞贝病的一种策略。
EMBO Mol Med. 2017 Mar;9(3):353-370. doi: 10.15252/emmm.201606547.
3
TFEB overexpression promotes glycogen clearance of Pompe disease iPSC-derived skeletal muscle.
Sci Rep. 2024 Apr 12;14(1):8052. doi: 10.1038/s41598-024-56912-7.
4
Fabry Disease: Cardiac Implications and Molecular Mechanisms.法布里病:心脏影响与分子机制。
Curr Heart Fail Rep. 2024 Apr;21(2):81-100. doi: 10.1007/s11897-024-00645-1. Epub 2024 Jan 30.
5
Advanced Cellular Models for Rare Disease Study: Exploring Neural, Muscle and Skeletal Organoids.用于罕见病研究的高级细胞模型:探索神经、肌肉和骨骼类器官。
Int J Mol Sci. 2024 Jan 13;25(2):1014. doi: 10.3390/ijms25021014.
6
Uniform transgene activation in Tet-On systems depends on sustained rtTA expression.在Tet-On系统中,转基因的均匀激活取决于rtTA的持续表达。
iScience. 2023 Aug 19;26(10):107685. doi: 10.1016/j.isci.2023.107685. eCollection 2023 Oct 20.
7
Induced Pluripotent Stem Cells for Modeling Physiological and Pathological Striated Muscle Complexity.诱导多能干细胞在模拟生理和病理横纹肌复杂性方面的应用。
J Neuromuscul Dis. 2023;10(5):761-776. doi: 10.3233/JND-230076.
8
Pathological modeling of glycogen storage disease type III with CRISPR/Cas9 edited human pluripotent stem cells.利用CRISPR/Cas9编辑的人类多能干细胞对III型糖原贮积病进行病理建模
Front Cell Dev Biol. 2023 May 11;11:1163427. doi: 10.3389/fcell.2023.1163427. eCollection 2023.
9
Simple and efficient differentiation of human iPSCs into contractible skeletal muscles for muscular disease modeling.高效分化人诱导多能干细胞为可收缩的骨骼肌用于肌肉疾病建模。
Sci Rep. 2023 May 25;13(1):8146. doi: 10.1038/s41598-023-34445-9.
10
Polymer-based drug delivery systems under investigation for enzyme replacement and other therapies of lysosomal storage disorders.用于酶替代治疗和其他溶酶体贮积症治疗的聚合物药物递送系统。
Adv Drug Deliv Rev. 2023 Jun;197:114683. doi: 10.1016/j.addr.2022.114683. Epub 2023 Jan 16.
TFEB 过表达促进庞贝病 iPSC 衍生骨骼肌中的糖原清除。
Mol Ther Methods Clin Dev. 2016 Aug 10;3:16054. doi: 10.1038/mtm.2016.54. eCollection 2016.
4
Early pathogenesis of Duchenne muscular dystrophy modelled in patient-derived human induced pluripotent stem cells.利用患者来源的人诱导多能干细胞建立杜氏肌营养不良症的早期发病机制模型。
Sci Rep. 2015 Aug 20;5:12831. doi: 10.1038/srep12831.
5
Disease modeling and lentiviral gene transfer in patient-specific induced pluripotent stem cells from late-onset Pompe disease patient.晚期庞贝病患者特异性诱导多能干细胞中的疾病建模和慢病毒基因转移。
Mol Ther Methods Clin Dev. 2015 Jul 8;2:15023. doi: 10.1038/mtm.2015.23. eCollection 2015.
6
Pompe disease results in a Golgi-based glycosylation deficit in human induced pluripotent stem cell-derived cardiomyocytes.庞贝氏病导致人类诱导多能干细胞衍生的心肌细胞中出现基于高尔基体的糖基化缺陷。
J Biol Chem. 2015 Jan 30;290(5):3121-36. doi: 10.1074/jbc.M114.628628. Epub 2014 Dec 8.
7
Suppression of mTORC1 activation in acid-α-glucosidase-deficient cells and mice is ameliorated by leucine supplementation.缺乏酸性α-葡萄糖苷酶的细胞和小鼠中 mTORC1 激活的抑制作用可通过补充亮氨酸得到改善。
Am J Physiol Regul Integr Comp Physiol. 2014 Nov 15;307(10):R1251-9. doi: 10.1152/ajpregu.00212.2014. Epub 2014 Sep 17.
8
Functional analysis of iPSC-derived myocytes from a patient with carnitine palmitoyltransferase II deficiency.从肉毒碱棕榈酰基转移酶 II 缺乏症患者的诱导多能干细胞中分离得到的肌细胞的功能分析。
Biochem Biophys Res Commun. 2014 May 30;448(2):175-81. doi: 10.1016/j.bbrc.2014.04.084. Epub 2014 Apr 26.
9
Derivation of myogenic progenitors directly from human pluripotent stem cells using a sphere-based culture.利用基于球体的培养方法,从人多能干细胞中直接分化出肌源性祖细胞。
Stem Cells Transl Med. 2014 May;3(5):564-74. doi: 10.5966/sctm.2013-0143. Epub 2014 Mar 21.
10
Myogenic differentiation of muscular dystrophy-specific induced pluripotent stem cells for use in drug discovery.肌源性分化肌营养不良症特异性诱导多能干细胞在药物发现中的应用。
Stem Cells Transl Med. 2014 Feb;3(2):149-60. doi: 10.5966/sctm.2013-0095. Epub 2014 Jan 6.